Key result
Hospitals without pharmacist-provided heparin or warfarin management had significantly higher death rates (11.41% and 6.20% higher, respectively; p<0.0001) than those with pharmacist management.
Why the study?
Does pharmacist-provided anticoagulation management improve clinical outcomes and reduce costs in hospitalized Medicare patients requiring anticoagulant therapy?
Population
717,396 Medicare patients treated in 955 United States hospitals for conditions requiring anticoagulant…
Comparison
Pharmacist-provided anticoagulation management vs Hospitals without pharmacist-provided…
Design
Cohort
Follow-up
Hospitalization (length of stay)
Authors
Loading...
Pharmacist anticoagulation services were associated with lower mortality and costs in Medicare inpatients; leaves open whether prospective trials should change practice.
Observational (n=717,396)
Yes
Does pharmacist-provided anticoagulation management improve clinical outcomes and reduce costs in hospitalized Medicare patients requiring anticoagulant therapy?
p-value: p=<0.0001
Pharmacist-provided anticoagulation management in hospitals is associated with significantly lower mortality, bleeding complications, length of stay, and healthcare costs.
Bond et al. (2004) conducted an observational in Conditions requiring anticoagulant therapy (n=717,396). Pharmacist-provided anticoagulation management vs. Hospitals without pharmacist-provided anticoagulation management was evaluated on Death rate, length of stay, Medicare charges, bleeding complications, and transfusions (p=<0.0001). Hospitals without pharmacist-provided heparin or warfarin management had significantly higher death rates (11.41% and 6.20% higher, respectively; p<0.0001) than those with pharmacist management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: